Trending News
Andes Virus Outbreak on a Cruise Ship: Current Situation | HantavirusHantavirus outbreak tests Trump officials who criticized covid responseHantavirus 101: What You Need to Know | FOX 10 TalksAndes Virus Outbreak on a Cruise Ship: Current Situation | HantavirusHantavirus outbreak tests Trump officials who criticized covid responseHantavirus 101: What You Need to Know | FOX 10 Talks

90-Second Read: Hantavirus treatments are coming but not fast enough for this outbreak, experts say

EP

Editorial voice

Elena Park

Published

Published May 12, 2026

Disclaimer
This is a simplified summary of outside reporting. Hantavirus Now did not independently report the original story. Read the original source for full details.This is a simplified summary of outside reporting. Hantavirus Now did not independently report the original story. Read the original source for full details.

In the meantime, public health officials and clinicians are working to contain an outbreak that began on a cruise ship last month that has so far sickened at least nine people, resulting in three deaths. But the Andes virus, the type of Hantavirus at the center of the current outbreak, is capable of spreading from person to person. We have the lead candidates, but we don't have the $25 [million] to $50 million to go the next step." Part of the reason for the lack of funding is the rarity of Hantavirus outbreaks. Hantavirus is typically spread to humans who are exposed to infected rodents or their feces or urine. There is no specific treatment for Hantavirus; rather clinicians try to support patients and treat symptoms as they arise.

Still, there are potential therapies on the horizon that experts say deserve more attention as the outbreak unfolds. Tony Schountz, an immunologist at Colorado State University, has studied antibody responses to Hantavirus in rodents for years. But Hantavirus isn't COVID, and even under a similarly accelerated timeline, any therapies would come too late to treat anyone who was infected on the cruise ship. More recently, his team has focused on searching for ways to prevent or treat the illness in people. That's unfortunate, because nobody cares until an outbreak occurs.

This can range from ensuring that infected people get rest and hydration to intubating patients with a severe case in which breathing is impaired, among other actions. Using white blood cells from humans infected with Hantavirus, the researchers identified antibodies-proteins in the immune system that can identify and neutralize pathogens-that may be able to combat different strains of the virus. Once the antibodies attach to that protein, they can disrupt Hantavirus's ability to bind to host cells. Botten says that he hopes the global attention on Hantavirus will register with policymakers and research funding groups. Still more are suspected to be infected, and because of the virus's long incubation time, more cases are almost certainly going to emerge.

In the U.S., fewer than 1,000 cases have been confirmed between 1993 and 2023. Ghebreyesus also noted that 34 passengers who left the boat before the outbreak was confirmed have been identified and located. While mortality rates from infection can be as high as 50 percent, depending on the virus type, as few as 10,000 infections occur globally each year, and most of these are in Asia and Europe, where the typical types are less fatal. He notes, however, that it can take a decade or more for treatments to go through all the steps to be approved for use in humans. World Health Organization director general Tedros Ghebreyesus said at a press conference on Tuesday that all the passengers have left the ship and will be monitored; the boat.

Source reference

Original reporting

Based on reporting from Scientific American. Read the original source for full details.

Source published May 12, 5:46 PM EDT. Hantavirus Now reviewed reporting from Scientific American and summarized the key points below.

Read original article